Back
ESC2025 Premium Access

Impact of Beta-Blocker Prescription at Discharge on Long-term Clinical Outcomes in ST elevation Myocardial Infarction Patients with Reduced LVEF treated with Drug-eluting Stents

Session: Pharmacotherapy in acute coronary syndromes (1)
Topic: ST-Elevation Myocardial Infarction (STEMI)
Speaker: Doctor S. Park (Seoul, KR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Soohyung Park

Korea University Guro Hospital, Seoul (Korea (Republic of))
0 follower

5 more presentations in this session

Impact of beta-blocker Nebivolol versus Carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents

Speaker: Doctor M. Susanti (Jawa Timur, ID)

Access
Abstract
Slides
Video
Like
Thumbnail

Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention and using direct oral anticoagulants

Speaker: Mr O. Emilsson (Lund, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Impact of guidelines on Newer P2Y12 inhibitor use among ACS patients undergoing PCI

Speaker: Doctor M. Mohamed (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Early initiation of PCSK9 inhibitors in acute STEMI: Interim results of safety and efficacy from the EARLY-STEMI trial

Speaker: Doctor M. Ali (Doha, QA)

Access
Abstract
Slides
Video
Like
Thumbnail

Efficacy and safety of ticagrelor versus clopidogrel in acute myocardial infarction-associated cardiogenic shock: a propensity score-matched analysis

Speaker: Doctor M. Presume (Lisbon, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Pharmacotherapy in acute coronary syndromes (1)

Speakers: Doctor S. Park, Doctor M. Susanti, Mr O. Emilsson, Doctor M. Mohamed, Doctor M. Ali...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources